Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia.
Keating M, Coutré S, Rai K, Osterborg A, Faderl S, Kennedy B, Kipps T, Bodey G, Byrd JC, Rosen S, Dearden C, Dyer MJ, Hillmen P.
Keating M, et al.
Clin Lymphoma. 2004 Mar;4(4):220-7. doi: 10.3816/clm.2004.n.002.
Clin Lymphoma. 2004.
PMID: 15072613